Clinical Trials

Idiopathic Pulmonary Fibrosis (IPF) Clinical Trials

At University Hospitals Cleveland Medical Center, our interstitial lung disease (ILD) specialists are committed to advancing care through groundbreaking research. We are currently enrolling eligible patients in clinical trials for idiopathic pulmonary fibrosis (IPF), providing access to potential new therapies and helping shape the future of treatment.

Interested in participating or learning more?

View our Current ILD Clinical Trials and Eligibility Criteria